
GC60161
Fedratinib Hydrochloride
Also listed as Fedratinib hydrochloride hydrate
Fedratinib hydrochloride hydrate (TG-101348 hydrochloride hydrate) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor with IC50s of 3 nM for both JAK2 and JAK2V617F kinase· Fedratinib hydrochloride hydrate shows 35- and 334-fold selectivity over JAK1 and JAK3, respectively· Fedratinib hydrochloride hydrate induces cancer cell apoptosis and has the potential for myeloproliferative disorders research
ChemicalCAS1374744-69-0MW615.62FormulaC27H40Cl2N6O4S
- CAS number
- 1374744-69-0
- Molecular weight
- 615.62
- Formula
- C27H40Cl2N6O4S
- Solubility
- DMSO: 250 mg/mL (406·09 mM)
- InChIKey
- QAFZLTVOFJHYDF-UHFFFAOYSA-N
- Catalogue number
- GC60161
- Brand
- GLPBIO
Computed properties PubChem CID 67517580 · TPSA 118 Ų · H-bond donors 6 · H-bond acceptors 10
- TPSA
- 118 Ų
- H-bond donors
- 6
- H-bond acceptors
- 10
- Rotatable bonds
- 11
- Heavy atoms
- 40
SMILES CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4.O.Cl.Cl
Computed descriptors from PubChem (CID 67517580), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il